North Star Investment Management Corp. Acadia Pharmaceuticals Inc Transaction History

North Star Investment Management Corp.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$31.65 - $46.87 $27,852 - $41,245	-880 Closed	0 $0
Q3 2019 Oct 03, 2019	BUY	$22.22 - $44.01 $19,553 - $38,728	880 New	880 $32,000
Q2 2019 Jul 15, 2019	SELL	$23.32 - $28.12 $20,521 - $24,745	-880 Closed	0 $0
Q3 2017 Oct 06, 2017	BUY	$29.49 - $38.37 $25,951 - $33,765	880	880 $33,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.68B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

Stay updated on North Star Investment Management Corp. with notifications on news.